June 26, 2020: "Soleno Therapeutics announced the closing of its previously announced underwritten public offering of 34,848,484 shares of its common stock, including 4,545,454...
Jun 26, 2020: "The Janssen Pharmaceutical Companies of Johnson & Johnson announced today its decision to discontinue the Phase 3 LOTUS study of STELARA®...
June 26, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
As part...
June 26, 2020: "Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol
Allergan, an...
Jun 26, 2020: "Novartis announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending...
Jun 26, 2020: "Novartis, a leader in immuno-dermatology and rheumatology, announced the Committee for Medicinal Products for Human Use (CHMP) of the EMA has...
June 24, 2020: The Food and Drug Administration approved pembrolizumab (KEYTRUDA) for patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is...
June 25, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
A new...
 June 25, 2020: "Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all...
June 25, 2020: "Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug to be recommended by...
June 24, 2020:"Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics, is pleased to announce that the Supreme Court of the United...